ctrl K

Pliant Therapeutics Inc. (PLRX)

NASDAQ: PLRX · Real-Time Price · USD

1.61

0.02 (1.26%)

At close: May 01, 2025, 3:59 PM

1.67

3.41%

Pre-market: May 02, 2025, 08:38 AM EDT

Pliant Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	1.58M	9.69M	7.57M	41.82M	57.05M	n/a	n/a
Cost of Revenue	n/a	n/a	3.68M	3.2M	n/a	n/a	666K	n/a
Gross Profit	n/a	1.58M	6M	4.37M	41.82M	57.05M	-666K	n/a
Operating Income	-228.37M	-184.15M	-127.2M	-19.99M	-41.65M	-1.23M	-30.91M	-18.35M
Interest Income	n/a	24.08M	4.67M	272K	478K	816K	688K	16K
Pretax Income	-210.3M	-161.34M	-123.32M	-19.71M	-41.53M	-631K	-30.28M	-18.33M
Net Income	-210.3M	-161.34M	-121.5M	-17.91M	-39.74M	185K	-30.28M	-20.62M
Selling & General & Admin	59.05M	57.93M	39.95M	27.56M	17.27M	10.93M	6.5M	3.82M
Research & Development	167.19M	127.8M	96.94M	77.55M	66.19M	47.35M	24.41M	14.53M
Other Expenses	n/a	n/a	n/a	-77.55M	-366K	-216K	-49K	n/a
Operating Expenses	228.37M	185.72M	136.88M	27.56M	83.46M	58.28M	30.91M	18.35M
Interest Expense	3.02M	1.27M	791K	272K	366K	216K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	185.72M	136.88M	27.56M	83.46M	58.28M	30.91M	18.35M
Income Tax Expense	n/a	n/a	-1.82M	-1.81M	-1.79M	-816K	639K	2.29M
Shares Outstanding (Basic)	60.54M	58.72M	42.02M	35.85M	35.55M	35.55M	16.51M	803.5K
Shares Outstanding (Diluted)	60.54M	58.72M	42.02M	35.85M	35.55M	35.55M	16.51M	803.5K
EPS (Basic)	-3.47	-2.75	-2.89	-0.5	-1.12	0.01	-1.83	-25.67
EPS (Diluted)	-3.47	-2.75	-2.89	-0.5	-1.12	0.01	-1.83	-25.67
EBITDA	-228.37M	-158.23M	-118.85M	-95.73M	-40.34M	-118K	-30.25M	-18.06M
EBIT	-189.22M	-160.07M	-122.53M	-97.26M	-41.65M	-1.23M	-30.91M	-18.35M
Depreciation & Amortization	-39.15M	1.84M	3.68M	3.2M	1.31M	1.11M	666K	292K